Intervention Protocol

You have free access to this content

Interventions for enhancing adherence to treatment in adults with bronchiectasis

  1. Amanda McCullough1,*,
  2. Cristin Ryan1,
  3. Judy M Bradley2,3,
  4. Brenda O'Neill2,
  5. Stuart Elborn4,5,
  6. Carmel Hughes1

Editorial Group: Cochrane Airways Group

Published Online: 19 MAR 2014

DOI: 10.1002/14651858.CD011023


How to Cite

McCullough A, Ryan C, Bradley JM, O'Neill B, Elborn S, Hughes C. Interventions for enhancing adherence to treatment in adults with bronchiectasis (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD011023. DOI: 10.1002/14651858.CD011023.

Author Information

  1. 1

    Queen's University Belfast, School of Pharmacy, Belfast, Northern Ireland, UK

  2. 2

    University of Ulster, Centre for Health and Rehabilitation Technologies (CHaRT), Institute of Nursing and Health Research, Newtownabbey, Northern Ireland, UK

  3. 3

    Belfast Health and Social Care Trust, Department Respiratory Medicine, Belfast, UK

  4. 4

    Queen's University Belfast, Centre for Infection and Immunity, Belfast, Northern Ireland, UK

  5. 5

    Belfast Health and Social Care Trust, Department of Respiratory Medicine, Belfast, UK

*Amanda McCullough, School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, UK. amanda.mccullough@qub.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 19 MAR 2014

SEARCH

References

Additional references

Altenburg 2013
  • Altenburg J, de Graaff CS, Stienstra Y, Sloos JH, van Haren EHJ, Koppers RJH, et al. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non–cystic fibrosis bronchiectasis. JAMA 2013;309(12):1251-9.
Bilton 2013
  • Bilton D, Daviskas E, Anderson SD, Kolbe J, King G, Stirling R, et al. A phase III randomised study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis. Chest 2013;144(1):215-25.
Gibson 2013
  • Gibson GJ, Loddenkemper R, Lundback B, Sibille Y. European Lung White Book. Sheffield: European Respiratory Society, 2013.
Haworth 2013
  • Haworth C, Foweraker J, Wilkinson P, Kenyon R, Bilton D. Multicenter randomized double blind placebo controlled trial of Promixin (colistin) delivered through the I-neb in patients with non-CF bronchiectasis and chronic Pseudomonas aeruginosa infection. American Journal of Respiratory and Critical Care Medicine 2013;187:A3511.
Haynes 2008
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
Lee 2013
McCullough 2013
  • McCullough AR, Hughes CM, Tunney MM, Elborn JS, Quittner AL, Bradley JM. Treatment adherence and health outcomes in patients with bronchiectasis infected with Pseudomonas aeruginosa. American Journal of Respiratory and Critical Care Medicine 2013;187:A5231.
Pasteur 2010
RevMan 2012
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Seitz 2012
  • Seitz A, Olivier KN, Adjemian J, Holland SM, Prevots DR. Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000-2007. Chest 2012;142(2):432-9.
Serisier 2013
  • Serisier DJ, Martin ML, McGuckin MA, Chen AC, Brain B, Biga S, et al. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non–cystic fibrosis bronchiectasis. JAMA 2013;309(12):1260-7.
Weycker 2005
  • Weycker D, Edelsberg J, Oster G, Tino G. Prevalence and economic burden of bronchiectasis. Clinical Pulmonary Medicine 2005;12(4):205-9.
WHO 2007
  • World Health Organisation. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. http://www.who.int/entity/gard/publications/GARD%20Book%202007.pdf (accessed 14 November 2013).
WHO 2010
  • World Health Organisation. Global status report on noncommunicable diseases. http://whqlibdoc.who.int/publications/2011/9789240686458_eng.pdf (accessed 14 November 2013).
Wilson 2013
  • Wilson R, Welte T, Polverino E, De Soyza A, Greville H, O'Donnell A, et al. Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a phase II randomised study. European Respiratory Journal 2013;41(5):1107-5.